#Sustainability #India #EcoVadis #Raichur #Shilpa Pharma

Shilpa Pharma Lifesciences Obtains EcoVadis Gold Medal

Shilpa Pharma Lifesciences Limited, part of Shilpa Medicare Limited, has recently celebrated an important milestone by receiving the EcoVadis Gold Medal. This prestigious recognition places the organization amongst the world's elite when it comes to sustainable business practices. EcoVadis, a renowned provider of business sustainability ratings, evaluated over 130,000 companies globally and Shilpa achieved an impressive score of 82 out of 100, ranking in the 98th percentile.

Commitment to Sustainability

This gold medal serves as a testament to Shilpa Pharma's robust Environmental, Social, and Governance (ESG) practices and its commitment to creating a sustainable pharmaceutical enterprise. The evaluation from EcoVadis considers four essential pillars: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. This recognition highlights Shilpa's dedication to responsible practices within the pharmaceutical sector.

Mr. Keshav Bhutada, the Executive Director and CEO of Shilpa Pharma Lifesciences, expressed the company's resolve regarding sustainability and innovation, emphasizing their importance in their Contract Development and Manufacturing Organization (CDMO) strategy. He stated, "The EcoVadis Gold Medal is a testimony to our relentless efforts toward responsible manufacturing, ethical governance, and inclusive growth that creates enduring value for patients and partners. We look forward to working with more global innovator companies."

Enhancing Global Reputation

Receiving the EcoVadis Gold Medal further strengthens Shilpa's reputation among international customers, investors, and partners. It solidifies their stance as a trusted CDMO with sustainability integrated into the core of their operations. Shilpa's commitment not only benefits their business but also contributes positively to society and the environment, aligning with global objectives towards sustainable and responsible manufacturing.

This achievement reflects the company’s strategic goals to maintain industry-leading practices while ensuring that the operations remain transparent and accountable. Shilpa Pharma is recognized for its contributions in various therapeutic areas, particularly oncology and infectious diseases, allowing them to serve patients in more than 80 countries.

Looking Ahead

As Shilpa Pharma Lifesciences looks to the future, the company aims to enhance its partnerships with global innovators in the pharmaceutical space. This growth strategy indicates that sustainability will continue to be a significant factor in their operations and outreach efforts. The EcoVadis Gold recognition not only boosts their credibility but also underscores the importance of sustainable initiatives in ensuring that the pharmaceutical industry can meet both current and future challenges.

In conclusion, Shilpa Pharma Lifesciences Limited is paving the way for more sustainable practices within the pharmaceutical sector. Their achievements demonstrate that economic growth and environmental stewardship can go hand in hand, setting a precedent for others in the industry to follow. The gold medal from EcoVadis is not just an accolade; it is a symbol of Shilpa's long-term commitment to responsible business practices that serve both societal needs and business excellence. For more about Shilpa Medicare, visit www.vbshilpa.com.